Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)Annals of oncology, 2015-08, Vol.26 (8), p.1547-1573 [Peer Reviewed Journal]2015 European Society for Medical Oncology ;The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdv249 ;PMID: 26026162Full text available |
|
2 |
Material Type: Article
|
The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. EducateAnnals of oncology, 2021-05, Vol.32 (5), p.579-581 [Peer Reviewed Journal]2021 ;2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. 2021 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.01.068 ;PMID: 33582237Full text available |
|
3 |
Material Type: Article
|
ESMO-Magnitude of Clinical Benefit Scale version 1.1Annals of oncology, 2017-10, Vol.28 (10), p.2340-2366 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx310 ;PMID: 28945867Full text available |
|
4 |
Material Type: Article
|
Treatment of 95 post-Covid patients with SSRIsScientific reports, 2023-11, Vol.13 (1), p.18599-18599, Article 18599 [Peer Reviewed Journal]The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-023-45072-9 ;PMID: 37919310Full text available |
|
5 |
Material Type: Article
|
ATR inhibition preferentially targets homologous recombination-deficient tumor cellsOncogene, 2015-06, Vol.34 (26), p.3474-3481 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Jun 25, 2015 ;Macmillan Publishers Limited 2015. ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/onc.2014.276 ;PMID: 25174396 ;CODEN: ONCNESFull text available |
|
6 |
Material Type: Article
|
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensusAnnals of oncology, 2020-10, Vol.31 (10), p.1320-1335 [Peer Reviewed Journal]2020 European Society for Medical Oncology ;Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. ;2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2020 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.07.010 ;PMID: 32745693Full text available |
|
7 |
Material Type: Article
|
Behavioral Immune Trade-Offs: Interpersonal Value Relaxes Social Pathogen AvoidancePsychological science, 2020-10, Vol.31 (10), p.1211-1221 [Peer Reviewed Journal]The Author(s) 2020 ;ISSN: 0956-7976 ;EISSN: 1467-9280 ;DOI: 10.1177/0956797620960011Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
A large-scale standardized physiological survey reveals functional organization of the mouse visual cortexNature neuroscience, 2020-01, Vol.23 (1), p.138-151 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2020 ;ISSN: 1097-6256 ;EISSN: 1546-1726 ;DOI: 10.1038/s41593-019-0550-9 ;PMID: 31844315Full text available |
|
9 |
Material Type: Article
|
Forced activation of Cdk1 via wee1 inhibition impairs homologous recombinationOncogene, 2013-06, Vol.32 (24), p.3001-3008 [Peer Reviewed Journal]Copyright Nature Publishing Group Jun 13, 2013 ;Macmillan Publishers Limited 2013. ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/onc.2012.296 ;PMID: 22797065 ;CODEN: ONCNESFull text available |
|
10 |
Material Type: Article
|
Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)The Lancet (British edition), 2017-08, Vol.390 (10097), p.871-881 [Peer Reviewed Journal]2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 26, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31444-7 ;PMID: 28711318Full text available |
|
11 |
Material Type: Article
|
BMI and lifetime changes in BMI and cancer mortality riskPloS one, 2015-04, Vol.10 (4), p.e0125261-e0125261 [Peer Reviewed Journal]COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Taghizadeh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Taghizadeh et al 2015 Taghizadeh et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0125261 ;PMID: 25881129Full text available |
|
12 |
Material Type: Article
|
iRECIST: guidelines for response criteria for use in trials testing immunotherapeuticsThe lancet oncology, 2017-03, Vol.18 (3), p.e143-e152 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 01, 2017 ;2017. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30074-8 ;PMID: 28271869 ;CODEN: LANCAOFull text available |
|
13 |
Material Type: Article
|
Monitoring the Crosstalk Between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 with PETMolecular imaging and biology, 2020-10, Vol.22 (5), p.1218-1225 [Peer Reviewed Journal]The Author(s) 2020 ;ISSN: 1536-1632 ;EISSN: 1860-2002 ;DOI: 10.1007/s11307-020-01496-7Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trialAnnals of oncology, 2016-04, Vol.27 (4), p.619-624 [Peer Reviewed Journal]2015 European Society for Medical Oncology ;The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdv577 ;PMID: 26598545Full text available |
|
15 |
Material Type: Article
|
Integrating molecular nuclear imaging in clinical research to improve anticancer therapyNature reviews. Clinical oncology, 2019-04, Vol.16 (4), p.241-255 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2019 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-018-0123-y ;PMID: 30479378Full text available |
|
16 |
Material Type: Article
|
Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)PloS one, 2014-01, Vol.9 (1), p.e82331 [Peer Reviewed Journal]COPYRIGHT 2014 Public Library of Science ;COPYRIGHT 2014 Public Library of Science ;2014 Gaillard et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Gaillard et al 2014 Gaillard et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0082331 ;PMID: 24416140Full text available |
|
17 |
Material Type: Article
|
Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaquesNature communications, 2020-12, Vol.11 (1), p.6296-6296, Article 6296 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-20141-z ;PMID: 33293558Full text available |
|
18 |
Material Type: Article
|
RECIST - learning from the past to build the futureNature reviews. Clinical oncology, 2017-03, Vol.14 (3), p.187-192 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Mar 2017 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2016.195 ;PMID: 27995946 ;CODEN: AJHYE6Full text available |
|
19 |
Material Type: Article
|
Neofunctionalisation of the Sli gene leads to self-compatibility and facilitates precision breeding in potatoNature communications, 2021-07, Vol.12 (1), p.4141-4141, Article 4141 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-24267-6 ;PMID: 34230471Full text available |
|
20 |
Material Type: Article
|
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion studyThe lancet oncology, 2019-08, Vol.20 (8), p.1124-1135 [Peer Reviewed Journal]Elsevier Ltd ;2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30328-6 ;PMID: 31257177Full text available |